KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Intangibles (2018 - 2025)

Historic Intangibles for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to $13.2 million.

  • Twist Bioscience's Intangibles fell 740.77% to $13.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $13.2 million, marking a year-over-year decrease of 740.77%. This contributed to the annual value of $13.4 million for FY2025, which is 727.31% down from last year.
  • Twist Bioscience's Intangibles amounted to $13.2 million in Q4 2025, which was down 740.77% from $13.4 million recorded in Q3 2025.
  • Twist Bioscience's Intangibles' 5-year high stood at $66.1 million during Q4 2021, with a 5-year trough of $1.2 million in Q1 2021.
  • For the 5-year period, Twist Bioscience's Intangibles averaged around $35.9 million, with its median value being $35.8 million (2021).
  • In the last 5 years, Twist Bioscience's Intangibles soared by 2573203.12% in 2021 and then tumbled by 7357.06% in 2024.
  • Twist Bioscience's Intangibles (Quarter) stood at $66.1 million in 2021, then decreased by 11.75% to $58.4 million in 2022, then dropped by 8.86% to $53.2 million in 2023, then tumbled by 73.28% to $14.2 million in 2024, then dropped by 7.41% to $13.2 million in 2025.
  • Its last three reported values are $13.2 million in Q4 2025, $13.4 million for Q3 2025, and $13.7 million during Q2 2025.